For the current quarter, analysts are expecting Glu Mobile Inc. (NASDAQ:GLUU) to report EPS of $-0.14. This consensus estimate is provided by Zacks Research. After the period that ended on 2017-03-31, Glu Mobile Inc. (NASDAQ:GLUU) reported an EPS actual of $-0.17. The difference between the actual and estimate resulted in a surprise factor of -88.89%. The company is expected to release their next earnings report on or around 2017-08-01. Interested parties will be watching to see how company results compare to what the Street was projecting for the fiscal period.
Shares of Glu Mobile Inc. (NASDAQ:GLUU) have a current ABR or average broker rating of 1.5. This consensus recommendation is also provided by Zacks Research. The recommendation falls on a scale between 1 and 5. A broker rating of 1 would translate into a Strong Buy. A rating of 5 would indicate a Strong Sell recommendation. This consensus broker rating may help shed some light on how the sell-side is currently viewing company stock.
Covering analysts often provide target price projections for company shares. The current Zacks consensus target price on shares of Glu Mobile Inc. (NASDAQ:GLUU) is $3.012. The top analyst target is $3.75, and the lowest target is $2.5 on the stock. Because of the different techniques used to gauge a company target price, estimates may be quite different from one analyst to another.
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) shares have a current ABR (average broker recommendation) of 1.72. This recommendation is offered by Zacks Research. The rating lands on a sliding numerical scale from 1 to 5. A recommendation of 5 would indicate a Strong Sell, and a 1 would signify a Strong Buy. The mean rating may help provide a general sense of analyst sentiment on company shares.
Sell-side analysts taken into consideration by Zacks have also provided price target estimates on shares of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN). The highest current target is $203. The lowest price target out of the polled analysts is presently $120. The consensus target price is currently noted at $159.533. Analysts may employ various techniques to help predict future stock price levels.
On the earnings front, Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) is expected to post quarterly earnings per share of $1.1. This is the current consensus figure provided by Zacks. Investors and analysts will be looking for the company to next post earnings on or around 2017-07-27. Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) most recently reported quarterly EPS of $1.2 for the quarter ending 2017-03-31. The gap between the actual and the projected estimate leading up to earnings created a surprise factor of 14.29%.